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Endothelial cells lining atherosclerotic, but not healthy sites, on human arteries express P-selectin. We investigated the role of
P-selectin on the development of vascular lesions in an ApoE−/− male mice. Double-knockout (ApoE−/−, P-selectin−/−;D K O )
were compared to single-knockout (ApoE−/−; SKO) mice. They were fed a chow or fat diet for 3, 6, 15, and 20 weeks, without any
diﬀerences in cholesterol levels. DKO mice fed a chow diet exhibited a ratio of lesion area over media lower than SKO mice, for 3
(P<. 03), 6 (P<. 001), and 15 (P<. 02) weeks. DKO mice fed a fat diet showed a lower ratio only at 3 weeks. P-selectin deﬁciency
in ApoE−/− mice has a protective eﬀect in atherosclerotic lesions development. Reduction of lesion size depends on diet type and
duration. A fat diet could neutralize the beneﬁcial eﬀects of P-selectin deﬁciency, inducing atherosclerotic lesions via probably
other adhesion molecules.
Copyright © 2006 Marie-Claude Bourdillon et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
INTRODUCTION
Extensive evidence is now available to show that P-selectin
(CD62P) [1, 2] plays a critical role in the homing of leuko-
cytes to sites of inﬂammation [3, 4]. Moreover, this adhe-
sion molecule is present in atherosclerotic lesions, but not
healthy sites, of human coronaries and carotid vessels [5].
These results have suggested that P-selectin may be impli-
cated, together with other adhesion molecules and cofactors,
in the initiation and perpetuation of atherosclerotic lesions.
Indeed, C57BL/6 mice with a single (ICAM-1, P-selectin or
CD18) or a double deﬁciency in adhesion molecules (ICAM-
1/CD18 or ICAM-1/P-selectin), fed a fat diet, were shown
to have a 50% to 75% reduction in fatty streak lesions com-
pared to wild-type mice [6]. Furthermore, P-selectin was as-
sociated with vascular remodelling in mice [7]a n dr a t[ 8]
carotid arteries.
Atherosclerotic mice models (ApoE−/−, LDLr−/−)h a v e
been shown to closely mimic human lesions [9–11]. More-
over,lesionsintheseanimalscanbeaccentuatedbytheuseof
ah ype r c holest e r ole micdiet[12,13].However,inacompara-
tive study between ApoE and LDLr deﬁcient mice, it was ob-
servedthatthetotalareaofatheroscleroticlesionswasgreater
at all times in ApoE−/− than LDLr−/− [14, 15]. It is conceiv-
able that the expression and role of adhesion molecules and
cofactors may slightly diﬀer between ApoE−/− and LDLr−/−
mice. P-selectin, or a combined P-o rE-selectin, deﬁciency
in an LDLr knockout, was shown to retards the onset of fatty
streak in cholesterol-rich fat-fed animals [16, 17]. Moreover,
P-selectin has also recently been shown to have a protec-
tive eﬀect in an ApoE knockout fed a chow diet for a spe-
ciﬁc period of time [18, 19]. The aim of this study was to
investigate the eﬀect of P-selectin deﬁciency on the devel-
opment of vascular lesions in ApoE knockout animals fed
a chow or a fat diet for diﬀerent periods of time. Results
show that P-selectin deﬁciency, in the ApoE knockout, im-
parts a protective eﬀect, over a period of up to 15 but not 20
weeks, in mice fed a chow diet. In contrast, this protective
eﬀect is only observed at 3 weeks when animals are fed a fat
diet.2 Journal of Biomedicine and Biotechnology
MATERIAL AND METHODS
Animalshandling
Surgical procedures and animal care strictly followed the
guidelines of the National Institute of Health and Medical
Research (Decree no 87-848 of 19th October 1987). All ani-
mals, used in this study, were ether-anaesthetised before or-
gan sampling.
Mice
The generation of the double-target mutation mice model
was carried out with two original knockout lines: the
Selptm1Bay [20] and the ApoEtm1Unc [1, 21]. The ApoE deﬁ-
cient mouse was made available to the European Network on
Atherosclerosis (ENA) thanks to Dr N. Maeda (University of
North Carolina). The Selptm1Bay line was made available to
the European Network on Atherosclerosis (ENA) thanks to
DrA.L.Beaudet(BaylorCollegeofMedicine,Tex,USA).The
ApoE deﬁcient mice were created by targeted inactivation of
ApoE gene, removing a fragment of the ApoE gene contain-
ing part of the exon 3 and part of the intron 3 which was re-
placed by the neo gene. The Selp (P-selectin) mice were cre-
ated by target mutation. The P-selectin gene was disrupted
by the deletion of a 4.5kb region containing exons 3–5. This
region was replaced by the Neo r from Pol2neobpA [22].
Originally, ApoEtm1Unc chimeras were mated to C57BL/6J
to obtain B6129F1 animals homozygous for the disrupted
gene. These founders were backcrossed 6 times to C57BL/6J
mice. A redirection by embryo transfer and three additional
backcross generations on C57BL/6JIco were conducted be-
fore intercrossing to obtain C57BL/6JIco-ApoEtm1Unc breed-
ing. The C57BL/6JIco-Selptm1Bay breeding colony was also
established after embryo rederivation and backcrossed with
C57BL/6J mice (Transgenic Alliance, Iﬀa Credo SA/Charles
River, Lyon, France). Both lines were maintained in speciﬁc
and opportunistic pathogen-free (SOPF) status by transfer
of the SOPD ﬂora and housing in ﬁlter-top cage system cou-
pled with laminar ﬂow working station in a full-barrier unit.
The double-mutant colony was generated under the same
housing conditions. Homozygous C57BL/6JIco-ApoEtm1Unc
and C57BL/6JIco-Selptm1Bay were mated to obtain heterozy-
gous mutants. These double heterozygous animals were in-
tercrossed to produce homozygous animals. These animals
were identiﬁed by a double protocol: total cholesterol-level
assay, for ApoE mutants and a PCR genotyping speciﬁc for
Selp. Total cholesterol measurement, performed on a blood
sample collected from the retroorbital sinus of anaesthetised
animals at the end of each observation period before sacri-
ﬁce, was determined using commercially available assay kits
(Boehringer Mannheim, France) and expressed in mmol/L.
For identiﬁcation of Selp P-selectin mutants, a classic PCR
was done on genomic DNA extracted from tail fragments
of the C57BL/6JIco-Selptm1Bay. Two separate PCR ampliﬁ-
cations, in view of the large size of the deletion (4.5kb),
were needed for the detection of Pol2neobpA cassette. The
sequence and exon of the oligonucleotides (Genosys, Cam-
bridge, UK) were as follows.
PCR1conductedtoanalysethedeletionofP-selectinexon3
5  TGTAAATCAGAAGGAAGTGGC 3  P-selectin exon 3 up-
stream primer (sense),
5  GTTACTCTTGATGTAGATCTCC 3  P-selectin exon 3
downstream primer (antisense);
PCR2 conducted to analyse the presence of the inserted
Pol2neobpAcassette
5  CAACTCATCTGGTTCAGTGC 3  P-selectin exon 2  up-
stream primer (sense),
5  GATATTGCTGAAGAGCTTGG 3  gene Neo down-
stream primer (sense).
The following conditions were applied: denaturation
(94◦C, 3min), ampliﬁcation for 35 cycles including denat-
uration (94◦C, 1min), annealing (56◦Ci nP C R 1o r5 8 ◦C
in PCR2, 30s) extension (72◦C, 1.30min), and a ﬁnal elon-
gation step (72◦C, 5min). Ampliﬁcation from wild-type P-
selectin DNA showed a 319bp fragment with PCR1 but no
ampliﬁcation product was obtained with PCR2. Ampliﬁca-
tion from heterozygous animals showed a 319bp fragment
(PCR1) and a 1040bp fragment (PCR2). After ampliﬁcation
from homozygous P-selectin mutants, no product was iden-
tiﬁed with PCR1 while a 1040bp fragment was identiﬁed
with PCR2.
Both male ApoE deﬁcient mice (n = 45) and double
homozygous mutants (C57BL/6JIco-ApoEtm1Unc and male
C57BL/6JIco-Selptm1Bay)( n = 45) were weaned at 3 weeks of
age and maintained on chow diet for 1 week (“Souriﬀarat”
breeding diet, standard formulation, pellets, irradiated at
25KGy, from Extralabo, France). Following that stage, they
either had access ad libitum to a chow (4% fat, 0% choles-
terol) or a Western-type diet (21% fat, 0.15% cholesterol,
special high-fat formulation, powder, irradiated at 25KGy,
fromUAR,France).Basalobservationsofcontrolgroupwere
made at time 0 in 4-week-old single ApoE deﬁcient and dou-
ble ApoE/P-selectin deﬁcient mice.
Histologicalandmorphometricanalysis
Animals were sacriﬁced after been anaesthetised by ether in-
halation. The heart, following incision of the thorax, was
brieﬂyperfused(2min)with4%paraformaldehyldeinphos-
phate buﬀer saline solution. The heart and the contigu-
ous thoracic aorta were then cut oﬀ and rapidly embedded
in tissue-Tek OCT compound (Miles, Elkhart, Ind). OCT-
treated samples were then frozen in liquid nitrogen. Sec-
tions (8µm thick) were mounted on gelatin-coated slides
a n ds t o r e da t−80◦C. Histological sections were air dried
and ﬁxed in cold acetone for 10min. Standard hematoxylin-
phloxin-safranin (HPS) staining was performed and lipids
were displayed with oil red O (ORO) staining.
Immunohistochemistry
Immediately before immunohistochemical staining, frozen
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Diet feeding time (weeks)
Apo-E SKO chow diet
Apo-E/P-selectin DKO chow diet
Apo-E SKO fat diet
Apo-E/P-selectin DKO fat diet
Figure 1: Plasma cholesterol levels in ApoE−/− (SKO) and ApoE−/−,
P-selectin−/− (DKO) mice. Levels of cholesterol for SKO or DKO an-
imals, fed a chow or fat diet, over 0 to 20 weeks. Mean ± SEM.
ﬁxed in 100% ice-cold acetone for 5min, and again air dried
for 15min. A circle was drawn to delimit the tissue using
a Dako pen (Dako Laboratories, Denmark). After incuba-
tion in blocking solution (5% goat serum, 0.5% BSA in PBS,
Gibco BRL, France; 30min, RT), sections were incubated
with 40µL of the diﬀerent monoclonal antibodies (mAbs)
a sd e s c r i b e db yO n r u s te ta l[ 23], for the identiﬁcation of
macrophages and endothelial cells. All incubation steps were
carried out in a humid chamber at RT, and were followed by
washes in 0.5% BSA in PBS (5min, 3 times).
Macrophages and endothelial cells were, respectively,
stainedwithMOMA-2(ratantibodydirectedagainstmurine
monocytes/macrophages, Serotec, Oxford, UK) and anti-CD
31 (PECAM-1, Pharmingen, San Diego, Calif) monoclonal
antibodies. A nonimmune monoclonal antibody of the same
species and class as the MOMA-2 and the anti-CD31 an-
tibodies, a rat IgG2a, (Pharmingen, San Diego, Calif) was
used as a negative control. Anti-von Willebrand factor (rab-
bit polyclonal, Dako, France, at a 1/250 dilution) was used
as a marker of endothelial cells. A biotinylated rabbit anti-
rat/mouse adsorbed IgG was used as second antibody (Vec-
tor Lab, Burlingame, Calif). Sections were developed using
avidin-biotin-horseradish peroxidase complex before AEC
(3-amino-9-ethylcarbazole)stainingproceduresasdescribed
[24].ABC-horseradishperoxidaseandAECchromogenwere
incubated 30min each. Slides with coverslips, using Immu-
Mount (Shandon Laboratories, Pittsburgh, Pa), were ob-
served after a nuclear counterstaining with hematoxylin.
Quantimetry
Ratio of lesion area to media area was performed through
the use of a Quantimet 600 Leica analyzer (Cambridge, UK).
Morphometric analysis of intima lesion area over media area
was carried out on the whole circumference of the prox-
imal aortic arch, using a previously described quantiﬁca-
tion method [6, 9, 25]. Measurements were performed on
ORO stained slides for the diﬀerent weeks of feeding (5 mice
per group). Results are expressed as mean (± SEM) of in-
tima/media area ratio. The diﬀerences between single (SKO)
and double (DKO) knockout mice groups were computed
using unpaired Student t test.
RESULTS
Cholesterollevels
Basal plasma cholesterol levels of ApoE−/− and ApoE−/−/P-
selectin−/− mice showed no diﬀerence (7.01 ± 1.21mmol/L
and 6.94 ± 1.19mmol/L, resp). These two animal models
showed no diﬀerences, over a period of time (3 to 20 weeks),
in cholesterol levels. Animals on a fat diet showed signiﬁ-
cantly higher cholesterol levels compared to those on chow
(Figure 1). Both animal models showed signiﬁcantly higher
cholesterol levels compared to wild-type mice (C57BL6) fed
a fat or chow diet (results not shown).
OROstainingandimmunohistochemistry
OilredOstainingshoweddiﬀerentstainingpatternsbetween
SKO and DKO mice. Aortic arch lesions staining in fat-fed
SKO animals were more extended, in the same time frame,
than in DKO animals. Moreover, fat diet accentuated the
presence of lipid-loaded cells in both types of animal models
(Figure 2, A to H). Macrophages, stained by MOMA-2 mon-
oclonal antibody, are shown binding the endothelial layer
andpenetratingtheintimallesionsinSKOandDKOanimals
following, respectively, 15- and 20-week chow diet (Figure 3,
A to D). Anti-von Willebrand factor and PECAM-1 labelling
allowed the identiﬁcation of the endothelial cell layer present
over lesion areas (results not shown).
Lesionarea/mediaarea
T h ep r o t e c t i v ee ﬀect, resulting from P-selectin deﬁciency, is
seen in all DKO animals, compared to SKO, fed a chow diet
from 3 to 15 weeks. Indeed, at 3, 6, 15, but not 20 weeks,
chow-fed DKO mice showed a lesion/media area ratio that
was signiﬁcantly lower compared to the SKO. Percentage re-





Figure 2: Oil red O staining of ApoE−/− (SKO) and ApoE−/−, P-selectin−/− (DKO) mice. The size of ORO-stained aortic lesions is observed
to be larger in SKO compared to DKO mice fed a 6- (a-b), 15- (c-d), and 20- (e-h) week fat diet. Lipid ORO-stained droplets are present in
aortic lesions from SKO and DKO lesions. At 20 weeks, total lumen obstruction of aortic arch is observed in an ApoE−/− animal (g). Black
arrows show atherosclerotic lesions. Original magniﬁcation: x100 ( a ,b ,f ,g ,h )a n dx250 (c, d, e).
respectively, 86, 64, and 89 % (Table 1, Figure 4). In contrast,
the protective eﬀect resulting from P-selectin deﬁciency, in
fat-fed DKO animals compared to SKO, was only seen at 3
weeks but not 6, 15, and 20 weeks. Percentage reduction in
lesion area/media area for 3 weeks was 78 % (P<. 001).
However,oneshouldnotetheexistenceofatendencyinthese
fat-fed DKO mice to show lower lesion size compared to the
SKO (Table 1, Figure 5).Marie-Claude Bourdillon et al 5
(a) (b)
(c) (d)
Figure 3: MOMA-2 staining of ApoE−/− (SKO) and ApoE−/−, P-selectin−/− ( D K O )m i c ef e dac h o wd i e t . Macrophages, stained by MOMA-2
monoclonal antibody, are shown binding the endothelial layer and penetrating the intimal lesions in SKO (a, c) and DKO (b, d) animals
following, respectively, 15- (a, b) and 20- (c, d) week chow diet. Black arrows show immunostained macrophages. Original magniﬁcation:
x250.
Table 1: Ratio of Lesion area/Media area. Values are mean ± SEM (SD) and express ratio (%) of Lesion area/Media area, measured in µ2.
(n = 5 mice per group) p values are shown for ApoE−/− (SKO) and ApoE−/−/P-Selectin−/− (DKO) mice fed a chow or fat diet from 0 to 20
weeks.
Chow diet Fat diet
Time ApoE−/− P ApoE−/−/P-Selectin−/− ApoE−/− P ApoE−/−/P-Selectin−/−
(weeks) (DKO versus SKO) (DKO versus SKO)
00 .95 ±0.09(0.20) P = 0.374 0.66 ±0.29(0.64) 0.95 ±0.09(0.20) P = 0.374 0.66 ±0.29(0.64)
31 0 .00 ±3.23(7.22) P<0.029 1.40 ±0.29(0.64) 10.77 ±1.48(3.31) P<0.001 2.40 ±0.86(1.92)
65 .38 ±0.51(1.15) P<0.001 1.90 ±0.50(1.13) 18.16 ±3.02(6.76) P = 0.239 10.27 ±5.42(12.12)
15 29.00 ±5.77(12.90) P<0.002 3.23 ±1.01(2.25) 98.22 ±29.51(65.98) P = 0.332 58.77 ±24.22(54.15)
20 66.93 ±8.36(18.70) P = 0.289 41.74 ±20.59(46.04) 122.91 ±23.34(52.19) P = 0.059 43.59 ±27.64(61.80)
DISCUSSION
This study shows for the ﬁrst time that the protective eﬀect,
imparted by P-selectin deﬁciency in ApoE−/−, is closely tied
to the type and duration of the diet. Several lines of evi-
dence back the above statement: (1) P-selectin deﬁciency in
ApoE−/− animals shows a signiﬁcant protection from inti-
mal/media remodelling compared to ApoE−/− in mice fed a
chowdiet.(2)TheP-selectinprotectiveeﬀectinchowfedan-
imalsissigniﬁcantat3,6,15,butnot20weeks.(3)P-selectin
deﬁciency in ApoE−/− animals fed a fat diet showed a protec-
tive eﬀect at 3 weeks but not at 6, 15, and 20 weeks.
Atherosclerotic lesions are the result of several events
occurring at the level of the vessel wall [26, 27]. Vascular
endothelial cells, activated at sites of inﬂammation, inter-
act with diﬀerent leukocyte subtypes. Intimal leukocyte ac-
cumulation is observed to occur at the onset of the arterial
disease [28]. However, as the disease progresses and the vas-
cular wall is remodelled, a reduction in leukocyte recruit-
ment is observed [14]. Such endothelial-leukocyte interac-
tions occur via adhesion molecules, chemokines, and diﬀer-
ent cofactors that are thought to play a key role in the ini-
tiation and perpetuation of atherosclerotic lesions [29, 30].
Among a number of adhesion molecules, implicated in the
homingofleukocytestositesofinﬂammation,endothelialP-
selectin has been reported to mediate transient adherence of
monocytes, neutrophils, and activated platelets to endothe-
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Time after chow diet (weeks)
Apo-E SKO
Apo-E/P-selectin DKO
Mean Apo-E SKO (n = 5)
Mean Apo-E/P-selectin DKO (n = 5)
Figure 4: Lesion area in ApoE−/− (SKO) and ApoE−/−, P-Selectin−/−
(DKO)micefedachowdiet.Ratiosoflesionareaovermediaareafor
SKO or DKOanimals fed a chow diet, over 0to 20weeks. Individual
values and means of SKO and DKO area ratios are shown for each
time.
ligand (PSGL-1) [35]. Several authors have also reported an
increased expression of P-selectin in atherosclerotic lesions
[6], as well as in vascular remodelling [7, 8].
Mice models, with a deﬁciency of ApoE or LDLr, are
thought to mimic vascular lesions observed in human
atherosclerosis [15]. One should note that results obtained
with the two mice models, namely, ApoE and LDLr deﬁ-
ciency, may slightly diﬀer in size of atherosclerotic lesions
[15]. Roselaar et al [14], in a comparative study between
ApoE and LDLr deﬁcient mice, observed that the total area
of atherosclerotic lesions was greater at all times in ApoE−/−
than LDLr−/−.I nt h i ss t u d y ,A p o Ed e ﬁ c i e n ta n i m a l sw e r e
comparedtothosehavinganApoEandP-selectindeﬁciency.
Results show that P-selectin deﬁciency signiﬁcantly reduces
the intima/media ratio area in the aortic arch regions of
ApoE−/− fed a chow diet. However, in our hands, such a re-
duction was observed for animals fed a chow diet over a pe-
riod of 3 to 15 weeks but not at 20 weeks. Surprisingly, on
feeding these animals a fat diet, the protective eﬀect of P-
selectin deﬁciency was limited to those fed for 3 weeks but
not at 6, 15, or 20 weeks. Our results, in contrast to the
team of Wagner et al [16] working on the same mice mod-
els, do not show a protection of P-selectin deﬁciency extend-
ing beyond 15 weeks of chow diet. In this study, we also ob-
serve that a fat diet can overcome any protective eﬀect of
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Time after fat diet (weeks)
Apo-E SKO
Apo-E/P-selectin DKO
Mean Apo-E SKO (n = 5)
Mean Apo-E/P-selectin DKO (n = 5)
Figure 5: Lesion area in ApoE−/− (SKO) and ApoE−/−, P-selectin−/−
(DKO) mice fed a fat diet. Ratios of lesion area over media area for
SKO or DKO animals fed a fat diet, over 0 to 20 weeks. Individual
values and means of SKO and DKO area ratios are shown for each
time.
call upon another member of the selectin family, E-selectin,
to take up the role of P-selectin. Indeed, double P-a n dE-
selectin deﬁciency in LDLr−/− mice appears to signiﬁcantly
extend the protective eﬀect of selectins [17, 36]. However,
plaque size and maturation were observed to be indepen-
dent of P-selectin deﬁciency in LDLr −/− mice when these
animals were fed a fat diet for an extended period of time
(37weeks)[16].Itisconceivablethatcertainadhesionrecep-
tors, in the absence of selectins, can act as backup molecules
to allow the extravasation of monocytes to sites of inﬂam-
mation at the level of the vessel wall. Recent data, obtained
with an ICAM-1 deﬁciency in ApoE−/− mice, have showed
reduced vascular lesions over a greater length of time, com-
pared to P-selectin, in fat-fed animals [37]. Indeed, the size
of atherosclerotic lesions and the length of protection may
greatly depend on the type of adhesion molecule that is be-
ing tested in ApoE−/− models in the presence of a chow or
fat diet. However, it is interesting to note that P-Selectin, but
notICAM-1,isimplicatedinneointimalgrowthaftercarotid
injury in ApoE-deﬁcient mice [38, 39]. Furthermore, inti-
mal lesions are lower in P-selectin antagonist-treated rats [8]
or mice [40]. Thus, P-selectin could be a potential target in
diagnostic and therapeutic strategies of atherosclerosis [41–
44].
Ourresultssuggestthat(1)P-selectindeﬁciencydisplays,
under normal conditions of diet, a protective role and de-
lays atherosclerotic plaque formation; (2) the hypercholes-Marie-Claude Bourdillon et al 7
terolemic diet triggers other mechanisms and adhesion re-
ceptors responsible of the genesis of atherosclerotic plaque;
(3) under prolonged hypercholesterolemic injury, P-selectin
deﬁciency protective eﬀect is overwhelmed. However, great
caution has to be taken in the interpretation of the data be-
tween animals fed a chow or a fat diet due to the small num-
b e ro fa n i m a l si ne a c hg r o u p( n = 5).
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